🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety, tolerability and phar...
Status
Completed
Location
ATTN-Research Pharmacist
Start Date
2012-04-30
Trial ID
NCT01597193
Treatments Being Tested
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
Primary Objective: To determine whether amcenestrant per overall survival ...
Status
Terminated
Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Start Date
2019-10-22
Trial ID
NCT04059484
Treatments Being Tested
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
This study plans to learn more about heart and vascular aging in men. In so...
Status
Completed
Location
University of Colorado CCTSI CTRC
Start Date
2016-07-01
Trial ID
NCT02758431
Treatments Being Tested
The primary objectives of this study are to determine whether the study dru...
Status
Completed
Location
Stanford University
Start Date
2017-12-07
Trial ID
NCT03229499
Treatments Being Tested
POLAR is a phase III clinical trial, which will test the safety and efficac...
Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Start Date
2019-08-27
Trial ID
NCT03820830
Treatments Being Tested
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Status
Completed
Location
Institut Bergonie
Start Date
2008-03-18
Trial ID
NCT00871858
Treatments Being Tested
This study is to investigate whether anastrozole ODF is bioequivalent with ...
Status
Completed
Location
Research Site
Start Date
2012-04
Trial ID
NCT01568281
Treatments Being Tested
This was a randomized, double-blind, placebo-controlled study conducted in ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-08-29
Trial ID
NCT03671330
Treatments Being Tested